Understanding human genetic factors influencing primaquine safety and efficacy to guide primaquine roll-out in a pre-elimination setting in southern Africa

BACKGROUND: Primaquine (PQ) is recommended as an addition to standard malaria treatments in pre-elimination settings due to its pronounced activity against mature Plasmodium falciparum gametocytes, the parasite stage responsible for onward transmission to mosquitoes. However, PQ may trigger haemolys...

Descripción completa

Detalles Bibliográficos
Autores principales: Awandu, Shehu S., Raman, Jaishree, Makhanthisa, Takalani I., Kruger, Philip, Frean, John, Bousema, Teun, Niemand, Jandeli, Birkholtz, Lyn-Marie
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2018
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5859786/
https://www.ncbi.nlm.nih.gov/pubmed/29558929
http://dx.doi.org/10.1186/s12936-018-2271-z

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5859786/
https://www.ncbi.nlm.nih.gov/pubmed/29558929
http://dx.doi.org/10.1186/s12936-018-2271-z

Ejemplares similares